The cost of Ofev can vary based on several factors, including your insurance coverage. The drug’s cost with and without insurance can depend on several factors, such as whether Ofev has a savings ...

Ofev has interactions with other drugs, including certain antibiotics and blood thinners. Taking these drugs with Ofev may increase the risk of Ofev’s side effects, including nausea, vomiting, and ...

RIDGEFIELD, Conn., Oct. 10, 2019 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to Ofev® (nintedanib), ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ofev (nintedanib) - Drug Insight and Market Forecast - 2030" - https ...

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

Pooled data from three key studies confirms that OFEV® slows disease progression by approximately 50% as measured by decline in forced vital capacity (FVC)*1-8 The pooled analysis also demonstrated ...

Boehringer Ingelheim has won a positive European Medicines Agency (EMA) recommendation for blockbuster Ofev’s (nintedanib) use in children and adolescents with progressive fibrosing interstitial lung ...

Driven by the idiopathic pulmonary fibrosis (IPF) market, Boehringer Ingelheim’s Ofev finally hit blockbuster sales in 2018. After following that performance with an FDA nod in a rare lung disease, ...

US and EU regulators have granted Orphan Drug Designation to Boehringer Ingelheim's Ofev for the treatment of systemic sclerosis, including the associated interstitial lung disease. The European ...

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other ...

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "OFEV Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report provides insights into OFEV for ...